Business
OrganOx metra® Receives FDA Approval for Operation During Air Transport, Expanding Access to Life-Saving Liver Perfusion Technology
Partnership with Strata Critical Medical (NASDAQ:SRTA) enables 24/7, device-to-donor support across the U.S.OrganOx Ltd., the organ technology company tackling the world's toughest transplant challenges, announced that its metra® normothermic machine perfusion (NMP) device has received approval from the U.S. Food and Drug Administration (FDA) for operation during air transport. This marks a major milestone in the company’s mission to make every organ count by supporting the broader utilization o
About this update from Strata Critical Medical, Inc.
[{"type":"image","alt":"ORGANOX LIMITED","displaySize":"","headline":null,"caption":"ORGANOX LIMITED","className":"","disableSlideshowImg":false,"size":{"original":{"width":218,"height":52,"url":"https://media.zenfs.com/en/globenewswire.com/ca252a38aed1b30c38ede554d96340d5"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/pzw2VZ0iQqwoRO0awZuBlg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEwMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/ca252a38aed1b30c38ede554d96340d5","width":218,"height":52}},"lazy":false},{"type":"text","content":"Partnership with Strata Critical Medical (NASDAQ:SRTA) enables 24/7, device-to-donor support across the U.S.","length":108,"tagName":"p"},{"type":"text","content":"OrganOx Ltd., the organ technology company tackling the world's toughest transplant challenges, announced that its metra® normothermic machine perfusion (NMP) device has received approval from the U.S. Food and Drug Administration (FDA) for operation during air transport. This marks a major milestone in the company’s mission to make every organ count by supporting the broader utilization of donor organs that might otherwise be discarded due to time, geographic distance or marginal liver function1,2.","length":508,"tagName":"p"},{"type":"text","content":"The FDA approval enables transplant centers and organ procurement organizations to safely transport donor livers on the metra® via chartered aircraft, significantly extending the reach of OrganOx’s technology to recipients from coast to coast. OrganOx anticipates increased adoption among U.S. transplant programs seeking to optimize outcomes while managing cost and operational complexity. With this capability, OrganOx metra® now aligns with the logistical flexibility of leading transplant transport systems while retaining its advantages in extended preservation times and enabling functional liver assessment.3,4","length":617,"tagName":"p"},{"type":"text","content":""This FDA approval is a major step forward for the transplant community," said Craig Marshall, CEO of OrganOx. "By enabling air transport of donor livers on the metra®, we're removing key logistical barriers to broader organ utilization and expanding access to our technology nationwide through our collaboration with Strata Critical."","length":359,"tagName":"p"},{"type":"text","content":""We are proud to be partnerin...